23 May 2013
Keywords: patent, challenge, zantac, uk, generics, subsidiary, amerpharm
Article | 06 March 1995
Generics (UK), a subsidiary of Amerpharm, has begun proceedings in the
UK against Glaxo over the validity of its patent ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 March 1995
27 March 1995
13 February 1995
© 2013 thepharmaletter.com